Dear Colleagues,
Few seats are still available for the *2nd European Training Course on Pharmacokinetics and Pharmacodynamics of Protein Therapeutics – Principles and Pharmacometric Approaches* Directed by Bernd Meibohm (University of Tennessee) and Johan Gabrielsson (Swedish University of Agricultural Sciences ) To be held in Darmstadt, Germany on *August 29-31, 2017*. Thanks to the sponsoring of Merck, seats for academics and students are available at a reduced fee (500€ instead of 1400€, including fees for course, lunches and coffee breaks) For more information, please contact us at cont...@ap2pop.org or click on the links below *Information:* *http://www.ap2pop.org/formations <http://www.ap2pop.org/formations>* *Registration form:* http://www.ap2pop.org/assets/PDF/Plaquette-formation-AP2POP-2017-PKPDofPT.pdf On behalf of the organising committee, *Emilie HENIN, PhD HDR* Consultant in Pharmacometrics AP2POP, Association pour la Promotion de la Pharmacocinétique de Population Secretary of AP2POP 2017-05-11 17:56 GMT+02:00 Emilie Henin <emilie.he...@gmail.com>: > Dear Colleagues, > > We are happy to announce the > > > > *2nd European Training Course on* > *Pharmacokinetics and Pharmacodynamics of Protein Therapeutics – > Principles and Pharmacometric Approaches * > that will be held in Darmstadt, Germany on August 29-31, 2017. > > The 3-day course is a shortened version of the course which has been given > for the last seven years by Prof Bernd Meibohm & Johan Gabrielsson in the > United States, and it is organized in EUROPE under the aegis of AP2POP and > with the sponsoring of Merck. > > > > During this course, you will be introduced to basic principles in the > pharmacokinetic and pharmacodynamic evaluation of novel therapeutic > proteins and hands-on exercises in the PK/PD evaluation of these compounds. > Topics include target-mediated drug disposition, tissue and tumor > penetration, first-in-human dose selection, immunogenicity, clinical > pharmacology challenges, biosimilars, and drug-drug interactions. The > target audience comprises pharmaceutical scientists from industry, academia > and regulatory agencies with basic knowledge in PK and PKPD that would like > to receive a comprehensive overview or refresher on the PK and PKPD of this > class of compounds. Hands-on exercises will be performed individually and > in small groups using simple software tools (no prior experience required). > > > > *Attendance and registration:* > > The attendance will be strictly limited to 35 participants, allowing nice > interactions. As well, a limited number of spots have been reserved for > academia and trainees for one third of the price thanks to Merck > sponsoring. > > > > For more detailed information on the preliminary course program, as well > as on the registration process, please visit: > > *Information:* http://www.ap2pop.org/formations > <http://www.ap2pop.org/fr/Formations> > > *Registration form:* http://www.ap2pop.org/assets/PDF/Plaquette-formation- > AP2POP-2017-PKPDofPT.pdf > > > > > Looking forward to seeing you in Darmstadt next summer ! > > > *The Course Directors* > Bernd Meibohm, University of Tennessee & Johan Gabrielsson, Swedish > University of Agricultural Sciences > > > > *The Local Organizers* > > Pascal Girard and Maike Puetter, Merck; Christian Laveille, Calvagone >
